PANews reported on December 29th, citing Cointelegraph, that a proposed 5% wealth tax on the net worth of billionaires in California has drawn strong oppositionPANews reported on December 29th, citing Cointelegraph, that a proposed 5% wealth tax on the net worth of billionaires in California has drawn strong opposition

Crypto executives criticize California's proposed 5% wealth tax

2025/12/29 11:00

PANews reported on December 29th, citing Cointelegraph, that a proposed 5% wealth tax on the net worth of billionaires in California has drawn strong opposition from cryptocurrency industry executives. The proposal, titled the "Billionaire Tax Act of 2026," would tax individuals or entities with a net worth exceeding $1 billion at 5% to fund healthcare and state aid programs. Because the tax would partially apply to unrealized gains, it could force wealthy individuals to sell assets to pay the tax. Industry figures such as Bitwise CEO Hunter Horsley and Kraken co-founder Jesse Powell have publicly opposed the move, arguing it would lead to an outflow of entrepreneurs and capital and questioning the efficiency of government spending. U.S. Representative Ro Khanna (California's 17th District) defended the proposal, stating that the funds would be used to improve childcare, housing, and education, contributing to American innovation.

Market Opportunity
The AI Prophecy Logo
The AI Prophecy Price(ACT)
$0.04234
$0.04234$0.04234
+8.14%
USD
The AI Prophecy (ACT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.